Diabetes

Showing NaN - NaN of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Insulin NPH, Diet/exercise)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin detemir
  • +2 more
  • Tucson, Arizona
  • +81 more
Aug 9, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Tuscumbia, Alabama
  • +116 more
Mar 1, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • Hamilton, Alabama
  • +83 more
Apr 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Alexander City, Alabama
  • +135 more
Mar 8, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)

Completed
  • Diabetes
  • +3 more
  • FlexTouch®
  • FlexPen®
  • Burlingame, California
  • +64 more
Feb 6, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • Goodyear, Arizona
  • +68 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +165 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Mesa, Arizona
  • +45 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide and metformin combination tablet
  • rosiglitazone and metformin combination tablet
  • Vestavia, Alabama
  • +102 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Bay Minette, Alabama
  • +186 more
Dec 16, 2016

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Phoenix, Arizona
  • +119 more
Dec 15, 2016

Diabetes, Diabetes, Type 2 Trial in Canada, Puerto Rico, United States (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin NPH
  • Birmingham, Alabama
  • +95 more
Jan 27, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Anaheim, California
  • +80 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Little Rock, Arkansas
  • +59 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (biphasic insulin aspart, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • insulin glargine
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes Trial in Worldwide (Ro 205-2349)

Completed
  • Diabetes
  • Ro 205-2349
  • Huntsville, Alabama
  • +116 more
Aug 23, 2016

Hypertension, Diabetes Trial in United States (Placebo, Azilsartan medoxomil)

Terminated
  • Hypertension
  • Diabetes
  • Placebo
  • Azilsartan medoxomil
  • Birmingham, Alabama
  • +67 more
Apr 20, 2015

Diabetes Trial in Georgia, India, United States (MBX-2982, Sitagliptin, )

Completed
  • Diabetes
  • Los Angeles, California
  • +13 more
Mar 30, 2015